Cargando…

Altered expression pattern of miR-29a, miR-29b and the target genes in myeloid leukemia

OBJECTIVES: The miR-29 family have been demonstrated acting as vital tumor suppressor in multiple cancers as well as regulators in the adaptive immune system. Little is known about their role in leukemogenesis. The purpose of this study is to analyze the expression pattern of miR-29a/29b and its tar...

Descripción completa

Detalles Bibliográficos
Autores principales:	Xu, Ling, Xu, Yan, Jing, Zhenyi, Wang, Xu, Zha, Xianfeng, Zeng, Chengwu, Chen, Shaohua, Yang, Lijian, Luo, Gengxin, Li, Bo, Li, Yangqiu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2014
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4086441/ https://www.ncbi.nlm.nih.gov/pubmed/25006537 http://dx.doi.org/10.1186/2162-3619-3-17

Ejemplares similares

Discovery and functional implications of a miR-29b-1/miR-29a cluster polymorphism in acute myeloid leukemia
por: Ngankeu, Apollinaire, et al.
Publicado: (2017)

MiR-29/Hsp47 in ECM network
por: Xu, Ren
Publicado: (2015)

Serum levels of miR-29, miR-122, miR-155 and miR-192 are elevated in patients with cholangiocarcinoma
por: Loosen, Sven H., et al.
Publicado: (2019)

Circulating miR-17, miR-20a, miR-29c, and miR-223 Combined as Non-Invasive Biomarkers in Nasopharyngeal Carcinoma
por: Zeng, Xi, et al.
Publicado: (2012)

The role of miR‐29 family in disease
por: Horita, Masahiro, et al.
Publicado: (2021)

Association of H-Type Hypertension with miR-21, miR-29, and miR-199 in Kazahks of Xinjiang, China
por: He, Xin, et al.
Publicado: (2022)

Predictive Value of Serum miR-10b, miR-29c, and miR-205 as Promising Biomarkers in Esophageal Squamous Cell Carcinoma Screening
por: Xu, Hang, et al.
Publicado: (2015)

The Roles of miR-26, miR-29, and miR-203 in the Silencing of the Epigenetic Machinery during Melanocyte Transformation
por: Gasque Schoof, Cláudia Regina, et al.
Publicado: (2015)

Metformin decreases miR-122, miR-223 and miR-29a in women with polycystic ovary syndrome
por: Udesen, Pernille Bækgaard, et al.
Publicado: (2020)

Interactive role of miR‐29, miR‐93, miR‐205, and VEGF in salivary adenoid cystic carcinoma
por: Bayat, Parisa, et al.
Publicado: (2022)

Differential Expression Profile of miR-27b, miR-29a, and miR-155 in Chronic Lymphocytic Leukemia and Breast Cancer Patients
por: Raeisi, Farzaneh, et al.
Publicado: (2020)

Application values of miR-194 and miR-29 in the diagnosis and prognosis of gastric cancer
por: Zhao, Xin, et al.
Publicado: (2018)

Assessment of the Diagnostic Potential of miR-29a-3p and miR-92a-3p as Circulatory Biomarkers in Acute Myeloid Leukemia
por: Gado, Marwa M, et al.
Publicado: (2019)

Diagnostic and prognostic potential of miR-21, miR-29c, miR-148 and miR-203 in adenocarcinoma and squamous cell carcinoma of esophagus
por: Hezova, Renata, et al.
Publicado: (2015)

Is miR-29 an oncogene or tumor suppressor in CLL?
por: Pekarsky, Yuri, et al.
Publicado: (2010)

A Systematic Review of miR-29 in Cancer
por: Kwon, Jason J., et al.
Publicado: (2018)

The Role of miR-29s in Human Cancers—An Update
por: Nguyen, Thuy T. P., et al.
Publicado: (2022)

Expression of miR-29c, miR-93, and miR-429 as Potential Biomarkers for Detection of Early Stage Non-Small Lung Cancer
por: Zhu, Wangyu, et al.
Publicado: (2014)

miR-29a suppresses the growth and metastasis of hepatocellular carcinoma through IFITM3
por: Liang, Yiming, et al.
Publicado: (2018)

Identification of Novel Targets for miR-29a Using miRNA Proteomics
por: Bargaje, Rhishikesh, et al.
Publicado: (2012)

Clinical significance of miR-372 and miR-495 in acute myeloid leukemia
por: Zhang, Wei, et al.
Publicado: (2020)

Plasma exosomal miR-1290 and miR-29c-3p as diagnostic biomarkers for lung cancer
por: Zhang, Qian, et al.
Publicado: (2023)

miR-29b, miR-205 and miR-221 Enhance Chemosensitivity to Gemcitabine in HuH28 Human Cholangiocarcinoma Cells
por: Okamoto, Kinya, et al.
Publicado: (2013)

Expression of miR-30c and miR-29b in prostate cancer and its diagnostic significance
por: Zhu, Chuanan, et al.
Publicado: (2018)

Plasma levels of miR‐29b and miR‐200b in type 2 diabetic retinopathy
por: Dantas da Costa e Silva, Maria Enoia, et al.
Publicado: (2018)

Bax Targeted by miR-29a Regulates Chondrocyte Apoptosis in Osteoarthritis
por: Miao, Guiqiang, et al.
Publicado: (2019)

miR-29b and miR-29c Are Involved in Toll-Like Receptor Control of Glucocorticoid-Induced Apoptosis in Human Plasmacytoid Dendritic Cells
por: Hong, Yongfeng, et al.
Publicado: (2013)

MiR-214 regulates CD3ζ expression in T cells
por: Xiao, Yankai, et al.
Publicado: (2019)

The relative expression of miR-31, miR-29, miR-126, and miR-17 and their mRNA targets in the serum of COVID-19 patients with different grades during hospitalization
por: Keikha, Reza, et al.
Publicado: (2021)

Correlation between Circulating miR-16, miR-29a, miR-144 and miR-150, and the Radiotherapy Response and Survival of Non-Small-Cell Lung Cancer Patients
por: Bache, Matthias, et al.
Publicado: (2023)

Neuronal miR-29a protects from obesity in adult mice
por: Ma, Yuan, et al.
Publicado: (2022)

miR-29b-3p Inhibitor Alleviates Hypomethylation-Related Aberrations Through a Feedback Loop Between miR-29b-3p and DNA Methylation in Cardiomyocytes
por: Wu, Fang, et al.
Publicado: (2022)

miR-29b contributes to multiple types of muscle atrophy
por: Li, Jin, et al.
Publicado: (2017)

ADAM12-L is a direct target of the miR-29 and miR-200 families in breast cancer
por: Duhachek-Muggy, Sara, et al.
Publicado: (2015)

Clinical response to azacitidine therapy depends on microRNA-29c (miR-29c) expression in older acute myeloid leukemia (AML) patients
por: Butrym, Aleksandra, et al.
Publicado: (2016)

MiR-29c-3p, a target miRNA of LINC01296, accelerates tumor malignancy: therapeutic potential of a LINC01296/miR-29c-3p axis in ovarian cancer
por: Xu, Hui, et al.
Publicado: (2020)

Circulating Plasma Levels of miR-20b, miR-29b and miR-155 as Predictors of Bevacizumab Efficacy in Patients with Metastatic Colorectal Cancer
por: Ulivi, Paola, et al.
Publicado: (2018)

Circulating miR-21, miR-29a, and miR-126 are associated with premature death risk due to cancer and cardiovascular disease: the JACC Study
por: Yamada, Hiroya, et al.
Publicado: (2021)

Decreased Expression of miR-21, miR-26a, miR-29a, and miR-142-3p in CD4(+) T Cells and Peripheral Blood from Tuberculosis Patients
por: Kleinsteuber, Katja, et al.
Publicado: (2013)

Differential expression of hsa-miR-221, hsa-miR-21, hsa-miR-135b, and hsa-miR-29c suggests a field effect in oral cancer
por: Lopes, Camile B., et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_md602vfcdpfohigp4suri8quqt